Market Tracker

01/20 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.43
Delayed Data
As of Jan 20
 -0.21 / -3.72%
Today’s Change
2.80
Today|||52-Week Range
7.80
-7.34%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close5.64
Today’s open5.71
Day’s range5.41 - 5.71
Volume1,686,140
Average volume (3 months)1,496,537
Market cap$575.4M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-21.16%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.57

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...-0.06-0.32%
RVNCRevance Therapeutics...-0.20-0.98%
VNDAVanda Pharmaceutical...-0.35-2.57%
ITCIIntra-Cellular Thera...-0.27-1.95%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts